Pioglitazone was associated with lower risk for adverse cardiovascular events than rosiglitazone in older patients: Commentary

Ananda Basu

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Pioglitazone was associated with lower risk for adverse cardiovascular events than rosiglitazone in older patients: Commentary'. Together they form a unique fingerprint.